Skip to main content

Ghost Tree Capital, LLC

SEC CIK
0001595851
Latest filing
Nov 14, 2024

AMLX holding history

Amylyx Pharmaceuticals, Inc. in every 13F filed by Ghost Tree Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMLX overviewAll 13F holders of AMLXFull Q3 2024 holdings

Shares (Q3 2024)
325,000
Value
$1.05M
% of portfolio
0.4%
Quarters held
6
Since Q3 2022
Holdings of AMLX by Ghost Tree Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 2024325,000$1.05M0.4%+325,000NewHolders
Q4 20230$00.0%−215,000−100.0%Sold outHolders
Q3 2023215,000$3.94M1.9%−335,000−60.9%ReducedHolders
Q2 2023550,000$11.9M4.3%+75,000+15.8%AddedHolders
Q1 2023475,000$13.9M5.3%+125,000+35.7%AddedHolders
Q4 2022350,000$12.9M5.5%−200,000−36.4%ReducedHolders
Q3 2022550,000$15.5M6.3%+550,000NewHolders